Consensus Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Equities

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
23.19 ^CNY	+1.35%		+1.84%	-7.35%

Apr. 24	Fosun Pharma Unit Gets Marketing Registration Approval for Tuberculosis Drug from Chinese Regulator	MT
Apr. 18	China Approves Fosun Unit's Phase 2 Clinical Trial for Cancer Combination Therapy	MT

dd.gWh87aM1BCVzGyZVsjWbxOQwqz70CMSBe1QqDzbDhWs.uTARmuxNNnwdS2xk_VPovJR-xlOxZIy2GBxndQ6T7B24Oki8_GVQXBUrdw~9f4816ff7dfb2ae05a39af4f2b3ba7ff

22-10-13

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

23.19 CNY

Average target price

29.75 CNY

Spread / Average Target

+28.28%

High Price Target

35 CNY

Spread / Highest target

+50.93%

Low Price Target

24.5 CNY

Spread / Lowest Target

+5.65%

Trading Rating

Investor Rating

ESG Refinitiv